- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1876-6250
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Medications that interact with direct-acting oral anticoagulant exposure ; volume:29 ; number:9 ; day:18 ; month:8 ; year:2021 ; pages:417-418 ; date:9.2021
Netherlands heart journal ; 29, Heft 9 (18.8.2021), 417-418, 9.2021
- Urheber
-
Vries, T. A. C. de
Groot, J. R. de
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12471-021-01617-z
- URN
-
urn:nbn:de:101:1-2021111219204573652010
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vries, T. A. C. de
- Groot, J. R. de
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Direct-acting antivirals and visceral leishmaniasis: a case report
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Direct-acting antivirals and visceral leishmaniasis: a case report
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Direct-acting antivirals and visceral leishmaniasis: a case report
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis